Passage Bio, Inc. (PASG) Reports In-Line Q1 EPS

Passage Bio, Inc. (NASDAQ: PASG) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25).

For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• Amazon: to grow Louisiana data center investment from $12 billion to $18 billion with a third data center campus
• U.S. mulls smaller military presence in Gulf once war ends - WaPo